Table 2 |
|||||
|
Number of cells stained positive in CIOA joints on Day 30 |
|||||
|
Bone markers |
|||||
|
|
|||||
|
Groups |
RANKL |
BMP2 |
TGF-β3 |
pSMAD2 |
DKK1 |
|
|
|||||
|
Healthy |
5 ± 1 |
nd |
109 ± 12 |
18 ± 3 |
75 ± 12 |
|
CIOA |
65 ± 12 |
136 ± 21 |
145 ± 22 |
36 ± 6 |
32 ± 9 |
|
CIOA+Glu1 |
8 ± 1*** |
102 ± 10* |
112 ± 14* |
12 ± 3*** |
89 ± 13*** |
|
|
|||||
|
Joint sections were obtained and stained as described in Figure 6. The number of positive cells was evaluated by a computerized imaging system. Data represent the mean of positive cells ± SD from two independent experiments involving five mice/group (10 joint sections/mice); nd, not detectable; Mann-Whitney U-test; *P < 0.05, ***P < 0.001 vs CIOA group. BMP, bone morphogenetic protein; CIOA, collagen-induced osteoarthritis; DKK1, Dickkopf-1; Glu, glucosamine hydrochloride; pSMAD-2, phosphorylated protein mothers against decapentaplegic homolog 2; RANKL, receptor activator of nuclear factor kappa B ligand; SD, standard deviation; TGF, transforming growth factor. |
|||||
|
Ivanovska and Dimitrova Arthritis Research & Therapy 2011 13:R44 doi:10.1186/ar3283 |
|||||